Veterinary Parasitic Vaccines: Current Status and Future Directions

Dear Colleagues,

Veterinary parasitic diseases are caused by a range of parasites, with major impacts on animal health and productivity, causing severe economic losses in livestock. The causative agents of parasitic diseases include protozoa, helminths and ectoparasites, which require different prevention and control strategies.

Parasites use complex mechanisms, including antigenic variation, to escape host immune responses, which may lead to immune modulation and result in long-term persistent infections. Therefore, the control of parasitic diseases is challenging and usually requires advanced diagnostics and integrated control measures including chemotherapy, vaccines and management. 

This Special Issue, “Veterinary Parasitic Vaccines: Current Status and Future Directions”, aims to gather knowledge concerning the use of currently available vaccines (drawbacks and advantages) and future trends in the development of vaccines against protozoa, helminths and ectoparasites. Thus, all manuscripts related to parasitic vaccine development (new approaches), epidemiological data for current and forthcoming vaccines, clinical trials, disease outbreaks, parasites’ immune responses, antigenic variation, host/parasite interactions, DIVA diagnostics, adjuvants and vectored vaccines, and general research on traditional and novel parasitic diseases will be welcomed. 

Dr. Monica Leszkowicz Mazuz
Dr. Carlos E. Suarez
Dr. Sharon Tirosh-Levy
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.